| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.279.4.281 |
| P953 | full work available at URL | http://jamanetwork.com/journals/jama/fullarticle/187180 |
| P698 | PubMed publication ID | 9450711 |
| P2093 | author name string | J. P. Ioannidis | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| statistical data interpretation | Q67369489 | ||
| randomized controlled trial | Q1436668 | ||
| publishing | Q10896657 | ||
| P304 | page(s) | 281-286 | |
| P577 | publication date | 1998-01-01 | |
| 1998-01-28 | |||
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials | |
| Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials | |||
| P478 | volume | 279 |
| Q37376463 | A Pocock approach to sequential meta-analysis of clinical trials |
| Q38108647 | A Primer on Performing Systematic Reviews and Meta-analyses |
| Q35738840 | A critical appraisal of epidemiological studies comes from basic knowledge: a reader's guide to assess potential for biases |
| Q50925108 | A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension |
| Q34524277 | A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations. |
| Q90696668 | A multi-state model analysis of the time from ethical approval to publication of clinical research studies |
| Q36239618 | A retrospective analysis of dissemination biases in the brief alcohol intervention literature |
| Q55305080 | A snapshot of translational research funded by the National Institutes of Health (NIH): A case study using behavioral and social science research awards and Clinical and Translational Science Awards funded publications. |
| Q30413920 | Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups |
| Q52970838 | Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis |
| Q24273224 | An exploratory test for an excess of significant findings |
| Q38877106 | An increasing problem in publication ethics: Publication bias and editors' role in avoiding it. |
| Q33819758 | Analysis of Pediatric Clinical Drug Trials for Neuropsychiatric Conditions |
| Q38106761 | Analysis of characteristics of randomized clinical trials in leukemia that are associated with how results are reported |
| Q36735497 | Annual International Geographic Medicine Congress Meetings in Shiraz, Iran: Publication Rates during 1999-2006 |
| Q29994473 | Anxiety: There is an app for that. A systematic review of anxiety apps |
| Q85036838 | Are results from pharmaceutical-company-sponsored studies available to the public? |
| Q41161926 | Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis |
| Q36673516 | Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting |
| Q34876707 | Assessment of the Reporting Quality of Randomized Controlled Trials on the Treatment of Diabetes Mellitus with Traditional Chinese Medicine: A Systematic Review |
| Q44635848 | Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk |
| Q54542309 | Association between interleukin-4 -590C > T polymorphism and non-Hodgkin's lymphoma risk. |
| Q98195612 | Association between polymorphisms in mannose-binding lectin 2 gene with pulmonary tuberculosis susceptibility |
| Q43406769 | Association between statistical significance and time to publication among systematic reviews: a study protocol for a meta-epidemiological investigation |
| Q45245187 | Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis |
| Q58560446 | Association between three genetic variants in kallikrein 3 and prostate cancer risk |
| Q37027800 | Association of Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms with Cancer: A Meta-Analysis |
| Q34614761 | Association of SMAD7 rs12953717 Polymorphism with Cancer: A Meta-Analysis |
| Q46949052 | Association of a common genetic variant in RNASEL and prostate cancer susceptibility |
| Q33935316 | Association of a common genetic variant in prostate stem cell antigen with cancer risk |
| Q52967308 | Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis |
| Q24288921 | Association of trial registration with the results and conclusions of published trials of new oncology drugs |
| Q30831418 | Attentional bias modification in depression through gaze contingencies and regulatory control using a new eye-tracking intervention paradigm: study protocol for a placebo-controlled trial. |
| Q24793279 | Balancing commercial and public interests |
| Q36367067 | Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines Agency |
| Q37280514 | Beyond the Randomized Controlled Trial: A Review of Alternatives in mHealth Clinical Trial Methods. |
| Q45205755 | Bias in genetic association studies: effects of research location and resources |
| Q55970050 | Bias in peer review |
| Q40478543 | Building partnerships: a pilot study of stakeholders' attitudes on technology disruption in behavioral health delivery and research. |
| Q77326667 | Can quality of clinical trials and meta-analyses be quantified? |
| Q89766581 | Challenges for funders in monitoring compliance with policies on clinical trials registration and reporting: analysis of funding and registry data in the UK |
| Q33708509 | Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov |
| Q91657238 | Characteristics, results, and reporting of contemporary surgical trials: A systematic review and analysis |
| Q64100773 | Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov |
| Q35642930 | Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review |
| Q24235035 | Comparison of protocols and registry entries to published reports for randomised controlled trials |
| Q45951344 | Comparison of published and unpublished phase I clinical cancer trials: an analysis of the CliniclTrials.gov database. |
| Q38617982 | Comparison of veterinary drugs and veterinary homeopathy: part 2. |
| Q52992795 | Delay and failure to publish dental research |
| Q77879660 | Design and quality considerations for randomized controlled trials in systemic sclerosis |
| Q49412555 | Development and testing of TraumaGameplay: an iterative experimental approach using the trauma film paradigm |
| Q102064021 | Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results |
| Q41880985 | ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies |
| Q36338448 | Effects of cognitive bias modification on social anxiety: A meta-analysis |
| Q47324266 | Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis. |
| Q26851353 | Efficacy of cognitive bias modification interventions in anxiety and depression: meta-analysis |
| Q39218509 | Establishment of genetic associations for complex diseases is independent of early study findings |
| Q24289214 | Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease |
| Q34255359 | Evidence on interventions to reduce medical errors: an overview and recommendations for future research |
| Q24288780 | Evolution and translation of research findings: from bench to where? |
| Q34357780 | Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses |
| Q24289247 | Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses |
| Q47097509 | Examining publication bias-a simulation-based evaluation of statistical tests on publication bias |
| Q24288672 | Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries |
| Q30920608 | Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies |
| Q73343446 | FDA: untapped source of unpublished trials |
| Q50671749 | Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form |
| Q33937155 | Factors predicting completion and time to publication of Cochrane reviews |
| Q57765782 | Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design? |
| Q33217505 | Fate of biomedical research protocols and publication bias in France: retrospective cohort study |
| Q24288733 | Following 411 Cochrane protocols to completion: a retrospective cohort study |
| Q37704021 | From Poster Presentation to Publication: National Congress of Child and Adolescent Psychiatry |
| Q24244308 | Full publication of results initially presented in abstracts |
| Q24245597 | Full publication of results initially presented in abstracts |
| Q63367934 | Full publication of results initially presented in abstracts |
| Q37497269 | Funding source and the quality of reports of chronic wounds trials: 2004 to 2011. |
| Q28189245 | Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis |
| Q52885903 | GRADE guidelines: 5. Rating the quality of evidence: publication bias |
| Q37092317 | Gap in publication of comparative information on new medicines |
| Q24289017 | Gene polymorphisms in chronic periodontitis |
| Q43508915 | Generalized synthesis of evidence and the threat of dissemination bias. the example of electronic fetal heart rate monitoring (EFM). |
| Q35070873 | Genetic associations in large versus small studies: an empirical assessment |
| Q35119636 | Genetic associations: false or true? |
| Q33857712 | How can we improve the interpretation of systematic reviews? |
| Q47562184 | How to prove that your therapy is effective, even when it is not: a guideline |
| Q53080924 | IL-10 polymorphisms and prostate cancer risk: a meta-analysis |
| Q34391049 | Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews |
| Q38034107 | Immunoglobulins in adult sepsis and septic shock |
| Q52647393 | Impact of randomized controlled trials on neurosurgical practice in decompressive craniectomy for ischemic stroke. |
| Q34558642 | Improving safety reporting from randomised trials |
| Q35177554 | Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study |
| Q46632048 | Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility |
| Q44204184 | Late-starter sites in randomized controlled trials |
| Q43187215 | Marching ahead with clinical trial registration |
| Q24797709 | Materializing research promises: opportunities, priorities and conflicts in translational medicine |
| Q34009241 | Meta-analysis in hematology and oncology |
| Q34627273 | Meta-analysis in medical research |
| Q37115919 | Meta-analysis methods |
| Q37805625 | Methodological characteristics of academic clinical drug trials--a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005. |
| Q37008455 | Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls |
| Q37243145 | Mobile health technology evaluation: the mHealth evidence workshop |
| Q37099505 | Modeling the dissemination and uptake of clinical trials results |
| Q31146292 | Negative pressure wound therapy: potential publication bias caused by lack of access to unpublished study results data |
| Q24288901 | Negativland - a home for all findings in psychology |
| Q37315320 | No difference found in time to publication by statistical significance of trial results: a methodological review |
| Q37266348 | Non-publication of large randomized clinical trials: cross sectional analysis. |
| Q60488035 | Non-significant results in ecology: a burden or a blessing in disguise? |
| Q28752005 | Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications |
| Q34445701 | Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis |
| Q36008577 | Patient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey |
| Q40689809 | Patterns of patient enrollment in randomized controlled trials |
| Q36128904 | Pediatric versus adult drug trials for conditions with high pediatric disease burden |
| Q36591926 | Peer-reviewed publication of clinical trials completed for pediatric exclusivity |
| Q24673248 | Pharmaceutical industry sponsorship and research outcome and quality: systematic review |
| Q34726091 | Physicians' interpretation of "class effects": a need for thoughtful re-evaluation |
| Q33730688 | Pooling research results: benefits and limitations of meta-analysis |
| Q28485388 | Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results |
| Q36890188 | Presentation of continuous outcomes in randomised trials: an observational study |
| Q28591178 | Preventing the ends from justifying the means: withholding results to address publication bias in peer-review |
| Q37070233 | Primer: strengths and weaknesses of meta-analysis. |
| Q93360917 | Principles of designing a clinical trial: optimizing chances of trial success |
| Q90665238 | Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review |
| Q53091529 | Promoting transparency in pharmaceutical industry-sponsored research |
| Q36624659 | Protocol for a systematic review on the extent of non-publication of research studies and associated study characteristics |
| Q38108574 | Publication Bias, with a Focus on Psychiatry: Causes and Solutions |
| Q38102417 | Publication Times, Impact Factors, and Advance Online Publication in Ophthalmology Journals |
| Q24289398 | Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention |
| Q30360244 | Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. |
| Q35285377 | Publication bias in Kienböck's disease: systematic review |
| Q24241884 | Publication bias in clinical trials due to statistical significance or direction of trial results |
| Q33833322 | Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication |
| Q35092572 | Publication bias: raising awareness of a potential problem in dental research. |
| Q30410554 | Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination |
| Q90160217 | Publication language and the estimate of treatment effects of physical therapy on balance and postural control after stroke in meta-analyses of randomised controlled trials |
| Q24718169 | Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis |
| Q37592322 | Publication of trials funded by the National Heart, Lung, and Blood Institute |
| Q49773294 | Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials.gov results database |
| Q52906618 | Quality of reports of randomised trials and estimates of treatment efficacy |
| Q27008490 | Questioning the dichotomy between vegetative state and minimally conscious state: a review of the statistical evidence. |
| Q83164417 | RNASEL −1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case–control studies |
| Q24245576 | Randomisation to protect against selection bias in healthcare trials |
| Q41255731 | Randomized clinical trials in orthodontics are rarely registered a priori and often published late or not at all. |
| Q35890916 | Randomized clinical trials: what gets published, and when? |
| Q36858709 | Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise |
| Q55055406 | Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO |
| Q30574153 | Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data |
| Q57455980 | Registration of published randomized trials: a systematic review and meta-analysis |
| Q73046888 | Regression to the truth: replication of association in pharmacogenetic studies |
| Q34010458 | Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research |
| Q77839510 | Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis |
| Q51200927 | Relationships fade with time: a meta-analysis of temporal trends in publication in ecology and evolution |
| Q29615456 | Replication validity of genetic association studies |
| Q28474127 | Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation |
| Q21203744 | Reporting bias in medical research - a narrative review |
| Q37072945 | Reporting of clinical trials: a review of research funders' guidelines |
| Q34546127 | Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials |
| Q44500905 | Research without results: Inadequate public reporting of clinical trial results |
| Q37758438 | Review and pooled analysis of studies on -607(C/A) and -137(G/C) polymorphisms in IL-18 and cancer risk |
| Q38613965 | Review finds periodontal treatment has short term benefits for diabetics |
| Q37472770 | Safety and transparency of pediatric drug trials |
| Q37483108 | Searching for genes that matter in acute kidney injury: a systematic review. |
| Q24288769 | Selection in reported epidemiological risks: an empirical assessment |
| Q30652517 | Small-study effects and time trends in diagnostic test accuracy meta-analyses: a meta-epidemiological study. |
| Q27304353 | Smartphone-Based Psychotherapeutic Micro-Interventions to Improve Mood in a Real-World Setting. |
| Q37859975 | Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects |
| Q41045224 | Submission to multiple journals: a method of reducing time to publication? |
| Q46987043 | Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis |
| Q35869658 | Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. |
| Q37284556 | Systematic literature reviews and meta-analyses: part 6 of a series on evaluation of scientific publications |
| Q38051084 | Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer |
| Q29619094 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias |
| Q26851424 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review |
| Q37356008 | Systematic review protocol assessing the processes for linking clinical trial registries and their published results |
| Q24289441 | Systematic reviews can be produced and published faster |
| Q37946512 | Technical approaches to single port/incision laparoscopic appendicectomy: a literature review |
| Q34150632 | The 5 R's: an emerging bold standard for conducting relevant research in a changing world |
| Q95826163 | The CCCD guidelines |
| Q46742687 | The DEC-net European register of paediatric drug therapy trials: contents and context |
| Q37098181 | The Decline Effect in Cardiovascular Medicine: Is the Effect of Cardiovascular Medicine and Stent on Cardiovascular Events Decline Over the Years? |
| Q35745645 | The acceptability among health researchers and clinicians of social media to translate research evidence to clinical practice: mixed-methods survey and interview study |
| Q26967565 | The answer is 17 years, what is the question: understanding time lags in translational research |
| Q24282603 | The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey |
| Q35089231 | The assessment of systematic reviews in dentistry |
| Q55549462 | The effectiveness of virtual reality based interventions for symptoms of anxiety and depression: A meta-analysis. |
| Q30814884 | The fading of reported effectiveness. A meta-analysis of randomised controlled trials |
| Q77940033 | The importance of randomized clinical trials and evidence-based medicine: a clinician's perspective |
| Q38135314 | The prognostic value of elevated ezrin in patients with osteosarcoma |
| Q37424593 | The quality of meta-analyses of genetic association studies: a review with recommendations |
| Q42940808 | The relation between publication bias and clinical trials funding |
| Q42594567 | The search for apnea genes |
| Q33850625 | The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials |
| Q37641067 | The use of older studies in meta-analyses of medical interventions: a survey. |
| Q86568916 | Three common polymorphisms in the IL-4 gene and cancer risk: A meta-analysis involving 5,392 cases and 6,930 controls |
| Q33926962 | Three-Armed Trials Including Placebo and No-Treatment Groups May Be Subject to Publication Bias: Systematic Review |
| Q36953174 | Time to publication among completed clinical trials |
| Q36042378 | Time to publication among completed diagnostic accuracy studies: associated with reported accuracy estimates |
| Q37728440 | Time to publication for publicly funded clinical trials in Australia: an observational study |
| Q24245587 | Time to publication for results of clinical trials |
| Q36821043 | Time-Lag Bias in Trials of Pediatric Antidepressants: A Systematic Review and Meta-Analysis |
| Q28535706 | Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals |
| Q28476002 | Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis |
| Q50517279 | Underreporting of Research Biopsies from Clinical Trials in Oncology |
| Q53086095 | Update analysis of studies on the MMP-9 −1562 C>T polymorphism and cancer risk |
| Q47105072 | Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility |
| Q33399843 | Using genetic data in cognitive neuroscience: from growing pains to genuine insights |
| Q44962857 | VEGF -460C>T polymorphism and cancer risk: a meta-analysis |
| Q64287567 | What happens to intimate partner violence studies registered on clinicaltrials.gov? A systematic review of a clinical trials registry |
| Q29649956 | What is open peer review? A systematic review |
| Q57943305 | What makes a good genetic association study? |
| Q79761139 | [Evaluation of clinical research studies in a comprehensive cancer center] |
Search more.